EXHIBIT 99.1
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The following Unaudited Pro Forma Condensed Consolidated Financial Statements of Emdeon Corporation (“Emdeon”) present financial information giving effect to the sale of Emdeon Practice Services, Inc, accounted for in accordance with Statement of Financial Accounting Standards No. 144 (As Amended), “Accounting for the Impairment or Disposal of Long-Lived Assets.” The Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2006 presents the consolidated financial position of Emdeon, giving effect to the disposition as if it had occurred on June 30, 2006. The Unaudited Pro Forma Condensed Consolidated Statements of Operations for the six months ended June 30, 2006 and for the years ended December 31, 2005, 2004 and 2003 present the consolidated results of operations of Emdeon, giving effect to the disposition as if had occurred on January 1, 2003.
The historical consolidated financial statements of Emdeon have been adjusted to give effect to pro forma events that are (1) directly attributable to the sale, (2) factually supportable, and (3) with respect to the statements of operations, not expected to have a continuing impact on the consolidated results. You should read this information in conjunction with:
| | |
| • | the accompanying notes to the unaudited pro forma condensed consolidated financial statements, which describe certain estimates and assumptions made in preparing such financial statements and in making the adjustments reflected therein; |
|
| • | Emdeon’s separate historical unaudited financial statements as of and for the six months ended June 30, 2006 included in Emdeon’s Quarterly Report onForm 10-Q for the quarterly period ended June 30, 2006; and |
|
| • | Emdeon’s separate historical financial statements for the three years ended December 31, 2005, 2004 and 2003 included in Emdeon’s Annual Report on Form10-K for the year ended December 31, 2005. |
The unaudited pro forma condensed consolidated financial statements have been prepared for informational purposes only. The unaudited pro forma condensed consolidated financial statements are not necessarily indicative of what the financial position or results of operations actually would have been had the sale been completed at the dates indicated. In addition, the unaudited pro forma condensed consolidated financial statements do not purport to project the future financial position or results of operations of Emdeon.
PF-1
EMDEON CORPORATION
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
AS OF JUNE 30, 2006
(In thousands)
| | | | | | | | | | | | | | | | |
| | As
| | | Discontinued
| | | Pro Forma
| | | Pro Forma
| |
| | Reported | | | Operations (b) | | | Adjustments | | | Adjusted | |
|
ASSETS | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 92,210 | | | $ | (2,710 | ) | | $ | 524,000 | (a) | | $ | 613,500 | |
Short-term investments | | | 296,750 | | | | — | | | | — | | | | 296,750 | |
Accounts receivable, net | | | 239,024 | | | | (35,594 | ) | | | — | | | | 203,430 | |
Inventory | | | 14,486 | | | | (3,500 | ) | | | — | | | | 10,986 | |
Prepaid expenses and other current assets | | | 36,079 | | | | (4,060 | ) | | | — | | | | 32,019 | |
Assets related to discontinued operations | | | — | | | | 247,801 | | | | (247,801 | )(b) | | | — | |
| | | | | | | | | | | | | | | | |
Total current assets | | | 678,549 | | | | 201,937 | | | | 276,199 | | | | 1,156,685 | |
Marketable equity securities | | | 2,944 | | | | (54 | ) | | | — | | | | 2,890 | |
Property and equipment, net | | | 126,376 | | | | (17,748 | ) | | | — | | | | 108,628 | |
Goodwill | | | 1,110,521 | | | | (179,460 | ) | | | (18,077 | )(c) | | | 912,984 | |
Intangible assets, net | | | 238,213 | | | | (4,477 | ) | | | — | | | | 233,736 | |
Other assets | | | 47,837 | | | | (198 | ) | | | 35,000 | (a) | | | 82,639 | |
| | | | | | | | | | | | | | | | |
TOTAL ASSETS | | $ | 2,204,440 | | | $ | — | | | $ | 293,122 | | | $ | 2,497,562 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
Accounts payable | | $ | 15,135 | | | $ | (3,371 | ) | | $ | — | | | $ | 11,764 | |
Accrued expenses | | | 158,249 | | | | (13,055 | ) | | | 13,073 | (d) | | | 158,267 | |
Deferred revenue | | | 125,811 | | | | (45,584 | ) | | | — | | | | 80,227 | |
Liabilities related to discontinued operations | | | — | | | | 62,718 | | | | (62,718 | )(b) | | | — | |
| | | | | | | | | | | | | | | | |
Total current liabilities | | | 299,195 | | | | 708 | | | | (49,645 | ) | | | 250,258 | |
| | | | | | | | | | | | | | | | |
Convertible notes | | | 650,000 | | | | — | | | | — | | | | 650,000 | |
| | | | | | | | | | | | | | | | |
Other long-term liabilities | | | 15,946 | | | | (708 | ) | | | — | | | | 15,238 | |
| | | | | | | | | | | | | | | | |
Minority interest in WebMD Health Corp. | | | 53,811 | | | | — | | | | — | | | | 53,811 | |
| | | | | | | | | | | | | | | | |
Convertible redeemable exchangeable preferred stock | | | 98,650 | | | | — | | | | — | | | | 98,650 | |
| | | | | | | | | | | | | | | | |
Stockholders’ equity | | | 1,086,838 | | | | — | | | | 342,767 | | | | 1,429,605 | |
| | | | | | | | | | | | | | | | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | | $ | 2,204,440 | | | $ | — | | | $ | 293,122 | | | $ | 2,497,562 | |
| | | | | | | | | | | | | | | | |
PF-2
EMDEON CORPORATION
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2006
(In thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | | | | Less
| | | | | | | |
| | | | | Discontinued
| | | Pro Forma
| | | Pro Forma
| |
| | As Reported | | | Operations (e) | | | Adjustments (f) | | | Adjusted | |
|
Revenue: | | | | | | | | | | | | | | | | |
Services | | $ | 615,346 | | | $ | (124,798 | ) | | $ | 27,803 | | | $ | 518,351 | |
Products | | | 78,654 | | | | (28,180 | ) | | | — | | | | 50,474 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 694,000 | | | | (152,978 | ) | | | 27,803 | | | | 568,825 | |
Costs of operations: | | | | | | | | | | | | | | | | |
Services | | | 354,202 | | | | (67,958 | ) | | | 27,740 | | | | 313,984 | |
Products | | | 38,211 | | | | (15,980 | ) | | | — | | | | 22,231 | |
| | | | | | | | | | | | | | | | |
Total cost of operations | | | 392,413 | | | | (83,938 | ) | | | 27,740 | | | | 336,215 | |
Development and engineering | | | 30,197 | | | | (12,276 | ) | | | — | | | | 17,921 | |
Sales, marketing, general and administrative | | | 178,840 | | | | (36,690 | ) | | | 63 | | | | 142,213 | |
Depreciation and amortization | | | 38,309 | | | | (4,534 | ) | | | — | | | | 33,775 | |
Legal expense | | | 817 | | | | — | | | | — | | | | 817 | |
Advisory expenses | | | 4,104 | | | | (2,032 | ) | | | — | | | | 2,072 | |
Interest income | | | 8,854 | | | | (3 | ) | | | — | | | | 8,851 | |
Interest expense | | | 9,359 | | | | — | | | | — | | | | 9,359 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations before income tax provision and minority interest | | | 48,815 | | | | (13,511 | ) | | | — | | | | 35,304 | |
Income tax provision | | | 9,996 | | | | (1,388 | ) | | | — | | | | 8,608 | |
Minority interest in WebMD Health Corp., net of tax | | | (793 | ) | | | — | | | | — | | | | (793 | ) |
| | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | 39,612 | | | $ | (12,123 | ) | | $ | — | | | $ | 27,489 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.14 | | | | | | | | | | | $ | 0.10 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.13 | | | | | | | | | | | $ | 0.09 | |
| | | | | | | | | | | | | | | | |
Weighted-average shares outstanding used in computing income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | | 286,141 | | | | | | | | | | | | 286,141 | |
| | | | | | | | | | | | | | | | |
Diluted | | | 296,107 | | | | | | | | | | | | 296,107 | |
| | | | | | | | | | | | | | | | |
PF-3
EMDEON CORPORATION
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2005
(In thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | | | | Less
| | | | | | | |
| | | | | Discontinued
| | | Pro Forma
| | | Pro Forma
| |
| | As Reported | | | Operations (e) | | | Adjustments (f) | | | Adjusted | |
|
Revenue: | | | | | | | | | | | | | | | | |
Services | | $ | 1,123,646 | | | $ | (245,144 | ) | | $ | 53,771 | | | $ | 932,273 | |
Products | | | 153,233 | | | | (59,031 | ) | | | — | | | | 94,202 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 1,276,879 | | | | (304,175 | ) | | | 53,771 | | | | 1,026,475 | |
Costs of operations: | | | | | | | | | | | | | | | | |
Services | | | 641,754 | | | | (140,254 | ) | | | 53,708 | | | | 555,208 | |
Products | | | 75,293 | | | | (34,847 | ) | | | — | | | | 40,446 | |
| | | | | | | | | | | | | | | | |
Total cost of operations | | | 717,047 | | | | (175,101 | ) | | | 53,708 | | | | 595,654 | |
Development and engineering | | | 58,494 | | | | (22,841 | ) | | | — | | | | 35,653 | |
Sales, marketing, general and administrative | | | 333,288 | | | | (78,464 | ) | | | 63 | | | | 254,887 | |
Depreciation and amortization | | | 71,767 | | | | (10,862 | ) | | | — | | | | 60,905 | |
Legal expense | | | 17,835 | | | | — | | | | — | | | | 17,835 | |
Loss on investments | | | 6,365 | | | | — | | | | — | | | | 6,365 | |
Interest income | | | 21,531 | | | | (4 | ) | | | — | | | | 21,527 | |
Interest expense | | | 16,324 | | | | (2 | ) | | | — | | | | 16,322 | |
Other expense, net | | | 3,765 | | | | — | | | | — | | | | 3,765 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations before income tax provision and minority interest | | | 73,525 | | | | (16,909 | ) | | | — | | | | 56,616 | |
Income tax benefit | | | (357 | ) | | | (644 | ) | | | — | | | | (1,001 | ) |
Minority interest in WebMD Health Corp., net of tax | | | 908 | | | | — | | | | — | | | | 908 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | 72,974 | | | $ | (16,265 | ) | | $ | — | | | $ | 56,709 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.21 | | | | | | | | | | | $ | 0.17 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.21 | | | | | | | | | | | $ | 0.16 | |
| | | | | | | | | | | | | | | | |
Weighted-average shares outstanding used in computing income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | | 341,747 | | | | | | | | | | | | 341,747 | |
| | | | | | | | | | | | | | | | |
Diluted | | | 352,852 | | | | | | | | | | | | 352,852 | |
| | | | | | | | | | | | | | | | |
PF-4
EMDEON CORPORATION
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2004
(In thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | | | | Less
| | | | | | | |
| | | | | Discontinued
| | | Pro Forma
| | | Pro Forma
| |
| | As Reported | | | Operations (e) | | | Adjustments (f) | | | Adjusted | |
|
Revenue: | | | | | | | | | | | | | | | | |
Services | | $ | 1,006,192 | | | $ | (234,648 | ) | | $ | 53,861 | | | $ | 825,405 | |
Products | | | 154,159 | | | | (61,467 | ) | | | — | | | | 92,692 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 1,160,351 | | | | (296,115 | ) | | | 53,861 | | | | 918,097 | |
Costs of operations: | | | | | | | | | | | | | | | | |
Services | | | 593,467 | | | | (149,684 | ) | | | 53,861 | | | | 497,644 | |
Products | | | 72,964 | | | | (34,319 | ) | | | — | | | | 38,645 | |
| | | | | | | | | | | | | | | | |
Total cost of operations | | | 666,431 | | | | (184,003 | ) | | | 53,861 | | | | 536,289 | |
Development and engineering | | | 54,161 | | | | (21,020 | ) | | | — | | | | 33,141 | |
Sales, marketing, general and administrative | | | 324,027 | | | | (79,511 | ) | | | — | | | | 244,516 | |
Depreciation and amortization | | | 57,765 | | | | (9,058 | ) | | | — | | | | 48,707 | |
Legal expense | | | 9,230 | | | | — | | | | — | | | | 9,230 | |
Restructuring and integration charge | | | 4,535 | | | | — | | | | — | | | | 4,535 | |
Gain on investments | | | 457 | | | | — | | | | — | | | | 457 | |
Interest income | | | 18,717 | | | | (1 | ) | | | — | | | | 18,716 | |
Interest expense | | | 19,253 | | | | (2 | ) | | | — | | | | 19,251 | |
Other income, net | | | 121 | | | | (121 | ) | | | — | | | | — | |
| | | | | | | | | | | | | | | | |
Income from continuing operations before income tax provision | | | 44,244 | | | | (2,643 | ) | | | — | | | | 41,601 | |
Income tax provision | | | 4,910 | | | | (687 | ) | | | — | | | | 4,223 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | 39,334 | | | $ | (1,956 | ) | | $ | — | | | $ | 37,378 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.12 | | | | | | | | | | | $ | 0.12 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.12 | | | | | | | | | | | $ | 0.11 | |
| | | | | | | | | | | | | | | | |
Weighted-average shares outstanding used in computing income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | | 320,080 | | | | | | | | | | | | 320,080 | |
| | | | | | | | | | | | | | | | |
Diluted | | | 333,343 | | | | | | | | | | | | 333,343 | |
| | | | | | | | | | | | | | | | |
PF-5
EMDEON CORPORATION
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2003
(In thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | | | | Less
| | | | | | | |
| | | | | Discontinued
| | | Pro Forma
| | | Pro Forma
| |
| | As Reported | | | Operations (e) | | | Adjustments (f) | | | Adjusted | |
|
Revenue: | | | | | | | | | | | | | | | | |
Services | | $ | 799,268 | | | $ | (222,542 | ) | | $ | 45,336 | | | $ | 622,062 | |
Products | | | 164,712 | | | | (80,098 | ) | | | — | | | | 84,614 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 963,980 | | | | (302,640 | ) | | | 45,336 | | | | 706,676 | |
Costs of operations: | | | | | | | | | | | | | | | | |
Services | | | 492,555 | | | | (155,380 | ) | | | 45,336 | | | | 382,511 | |
Products | | | 72,384 | | | | (37,085 | ) | | | — | | | | 35,299 | |
| | | | | | | | | | | | | | | | |
Total cost of operations | | | 564,939 | | | | (192,465 | ) | | | 45,336 | | | | 417,810 | |
Development and engineering | | | 42,985 | | | | (18,169 | ) | | | — | | | | 24,816 | |
Sales, marketing, general and administrative | | | 282,482 | | | | (74,297 | ) | | | — | | | | 208,185 | |
Depreciation and amortization | | | 62,434 | | | | (10,959 | ) | | | — | | | | 51,475 | |
Legal expense | | | 3,959 | | | | — | | | | — | | | | 3,959 | |
Gain on investments | | | 1,659 | | | | — | | | | — | | | | 1,659 | |
Interest income | | | 22,901 | | | | (46 | ) | | | — | | | | 22,855 | |
Interest expense | | | 15,214 | | | | (13 | ) | | | — | | | | 15,201 | |
Other income, net | | | 4,218 | | | | — | | | | — | | | | 4,218 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations before income tax provision | | | 20,745 | | | | (6,783 | ) | | | — | | | | 13,962 | |
Income tax provision | | | 4,140 | | | | (451 | ) | | | — | | | | 3,689 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | 16,605 | | | $ | (6,332 | ) | | $ | — | | | $ | 10,273 | |
| | | | | | | | | | | | | | | | |
Income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic and diluted | | $ | 0.05 | | | | | | | | | | | $ | 0.03 | |
| | | | | | | | | | | | | | | | |
Weighted-average shares outstanding used in computing income from continuing operations per common share: | | | | | | | | | | | | | | | | |
Basic | | | 304,858 | | | | | | | | | | | | 304,858 | |
| | | | | | | | | | | | | | | | |
Diluted | | | 325,811 | | | | | | | | | | | | 325,811 | |
| | | | | | | | | | | | | | | | |
PF-6
NOTES TO THE UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
The pro forma adjustments related to the Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2006 assume the disposition took place on June 30, 2006 and are as follows:
(a) Represents estimated total cash proceeds from the sale of $565 million, net of approximately $35 million for the security escrow included in other assets and approximately $6 million of costs related to the transaction which excludes $2 million of transaction costs already reported in Emdeon’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2006. These amounts do not reflect any adjustments based on net working capital as of the closing.
(b) Represents the elimination of the assets and liabilities of Emdeon Practice Services.
(c) Reflects an estimate of the reversal of the portion of the income tax valuation allowances that were originally established in connection with the purchase accounting of prior acquisitions. These income tax valuation allowances were reversed as a result of the utilization of Emdeon’s net operating loss carryforwards in connection with the gain on this transaction.
(d) Represents an estimate of the federal, state and other taxes payable in connection with the gain on this transaction.
The pro forma adjustments to the Unaudited Pro Forma Condensed Consolidated Statements of Operations for the six months ended June 30, 2006 and for the years ended December 31, 2005, 2004 and 2003 assume the disposition took place on January 1, 2003 and are as follows:
(e) Represents the reduction of revenue and expenses as a result of the disposition of Emdeon Practice Services. These amounts do not consider any allocation of corporate overhead to the companies that were divested.
(f) Represents an adjustment to add backinter-company transactions between Emdeon Practice Services and other Emdeon businesses, which were previously eliminated in consolidation. The inter-company revenue is primarily comprised of(i) print-and-mail services and electronic data interchange (“EDI”) services provided by Emdeon Business Services to the Emdeon Practice Services customer base which was $23.5 million for the six months ended June 30, 2006 and $44.6 million, $43.2 million and $36.8 million for the years ended December 31, 2005, 2004 and 2003, respectively, and (ii) rebate activity, related to the submission of EDI transactions, which was reflected as revenue of Emdeon Practice Services and expense of Emdeon Business Services in the amount of $4.3 million for the six months ended June 30, 2006 and $9.1 million, $10.7 million and $8.5 million for the years ended December 31, 2005, 2004 and 2003, respectively. Rebate revenue is included in the Discontinued Operations column as it will not be included in revenue of the continuing operations.
PF-7